Journal
PEDIATRIC CARDIOLOGY
Volume 26, Issue 6, Pages 843-845Publisher
SPRINGER
DOI: 10.1007/s00246-004-0919-7
Keywords
recombinant factor VIIa; cardiopulmonary bypass; cardiac surgery; Glanzmann thrombasthenia
Categories
Ask authors/readers for more resources
Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available